Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - tranexamic acid, quantity: 100 mg/ml - injection, solution - excipient ingredients: water for injections - adults,for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - furosemide, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; nitrogen; sodium chloride - oedema: furosemide ? aft is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. it is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.,furosemide ? aft injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, furosemide ? aft is indicated by the intravenous route. parenteral use should be replaced with oral furosemide as soon as practical.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: acetic acid; chlorobutanol hemihydrate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tranexamic acid, quantity: 500 mg - injection, solution - excipient ingredients: water for injections - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - adults for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics for the reduction of peri? and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - oxytocin, quantity: 5 iu/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; glacial acetic acid - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 01 jan 1991 : prophylaxis of heat prostration or muscle cramps, chloride deficiency due to diuresis or salt restriction, prevention or treatment of extracellular volume depletion. parenteral - 0.9% (isotonic) nacl is used to restore sodium and chloride losses; to dilute or dissolve drugs for iv, im or sc use, flushing of iv catheters; extracellular fluid replacement; priming solution for hemodialysis; initiate and terminate blood transfusions so red blood cells will not hemolyze; metabolic alkalosis when there is fluid loss and mild sodium depletion. topical or irrigation - relief of inflamed, dry or crusted nasal membranes or as a topical irrigating or flush solution.

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - tranexamic acid, quantity: 500 mg - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - intravenous administration,adults,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Ireland - English - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - pentobarbital sodium - solution for injection - 200 milligram(s)/millilitre - pentobarbital - cats, dogs - neurological preparations